Nowadays, technology makes it easier to test your DNA, but it brings up ethical questions: What do I want to know about my DNA? What if my DNA data is sold? Give your opinion about the use of your DNA and help shaping tomorrow’s society with Sciensano on dnadebat.be.
The number of hospital-associated bloodstream infections remains stable since 2013 in Belgian hospitals. However, there are variations between hospitals. This according to research from Sciensano, the Belgian institute for health.
You are kindly invited to the first bilateral workshop of Sciensano and Institute Pasteur Lille, that will focus on antimicrobial resistance (AMR). This event is organised by Sciensano’s Scientific Direction ‘Infectious diseases in humans’. Grasp this opportunity to meet other experts and exchange experiences, know-how, ideas and expertise on various aspects of resistance in bacteria, viruses and fungi.
Program
You are cordially invited to the Belgian One Health Network launch event on Tuesday 5 November at the Sciensano site in Tervuren.
Sciensano, the Belgian institute for health, successfully completed a study on avian influenza at the end of July 2019. Sciensano is the Belgian National Reference Laboratory (NRL) for avian influenza.
A new study by the Belgian institute for health Sciensano estimates the annual cost of acute gastroenteritis for the Belgian economy at an amount comprised between 210 million and one billion euros. Higher than originally assumed, this estimate takes into account the direct and indirect costs of the disease for the entire population.
Just one year ago, on April 1st 2018, Sciensano was born. This first anniversary is the perfect opportunity to highlight some of the flagship projects and publications that marked the year 2018.
Sciensano organises together with the Federal Agency for the Safety of the Food Chain (FASFC), the 4th symposium on animal health, with presentations about fighting (re)emerging infectious diseases, a transboundary approach : focus on African Swine Feverprocine and poultry diseases.
Demographic ageing is one of the most serious challenges that Europe is currently facing. Older people are at greater risk of becoming frail and develop disability. However, since frailty is not an inevitable consequence of ageing, it can be prevented and treated to foster a longer and healthier life. Belgium participates in ADVANTAGE, the first EU Joint Action on Frailty.
The Health Status Report combines the results of different sources to estimate how healthy the Belgian is. In general, the Belgian is rather healthy, but there are some areas of improvement. In addition, there are significant inequalities, both regionally and socio-economically.
The online report is based on the most recent data and will be continuously updated with the results of new studies, so that health policy makers can develop policies on a continuous basis, based on current needs.
